• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大肠神经内分泌肿瘤:临床病理特征及淋巴结转移的预测因素

Neuroendocrine Tumors of the Large Intestine: Clinicopathological Features and Predictive Factors of Lymph Node Metastasis.

作者信息

Kojima Motohiro, Ikeda Koji, Saito Norio, Sakuyama Naoki, Koushi Kenichi, Kawano Shingo, Watanabe Toshiaki, Sugihara Kenichi, Ito Masaaki, Ochiai Atsushi

机构信息

Division of Pathology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center , Kashiwa , Japan.

Division of Surgical Oncology, National Cancer Center Hospital East, Kashiwa, Japan; Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo, Japan.

出版信息

Front Oncol. 2016 Jul 18;6:173. doi: 10.3389/fonc.2016.00173. eCollection 2016.

DOI:10.3389/fonc.2016.00173
PMID:27486567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4947973/
Abstract

A new histological classification of neuroendocrine tumors (NETs) was established in WHO 2010. ENET and NCCN proposed treatment algorithms for colorectal NET. Retrospective study of NET of the large intestine (colorectal and appendiceal NET) was performed among institutions allied with the Japanese Society for Cancer of the Colon and Rectum, and 760 neuroendocrine tumors from 2001 to 2011 were re-assessed using WHO 2010 criteria to elucidate the clinicopathological features of NET in the large intestine. Next, the clinicopathological relationship with lymph node metastasis was analyzed to predict lymph node metastasis in locally resected rectal NET. The primary site was rectum in 718/760 cases (94.5%), colon in 30/760 cases (3.9%), and appendix in 12/760 cases (1.6%). Patients were predominantly men (61.6%) with a mean age of 58.7 years. Tumor size was <10 mm in 65.4% of cases. Proportions of NET G1, G2, G3, and mixed adeno-neuroendocrine carcinoma (MANEC) were 88.4, 6.3, 3.9, and 1.3%, respectively. Of the 760 tumors, 468 were locally resected, and 292 were surgically resected with lymph node dissection. Rectal NET showed a higher proportion of NET G1, and colonic and appendiceal NET was more commonly G3 and MANEC. Of the 292 surgically resected cases, 233 NET G1 and G2 located in the rectum were used for the prediction of lymph node metastasis. Lymphatic and blood vessel invasion were independent predictive factors of lymph node metastasis. NET G2 cases showed more frequent lymph node metastasis than that seen in NET G1 cases, but this was not an independent predictor of lymph node metastasis. Of the 98 surgically resected cases <10 mm in size, we found 9 cases with lymph node metastasis (9.2%). All cases were NET G1, and eight of the nine cases were positive either for lymphatic invasion or blood vessel invasion. Using the WHO classification, we found NET in the large intestine showed a tumor-site-dependent variety of histological and clinicopathological features. Risk of lymph node metastasis in rectal NET was confirmed even in lesions smaller than 10 mm. Concordant assessment of vascular invasion will be required to estimate lymph node metastasis in small lesions.

摘要

2010年世界卫生组织(WHO)建立了神经内分泌肿瘤(NETs)的新组织学分类。欧洲神经内分泌肿瘤学会(ENET)和美国国立综合癌症网络(NCCN)提出了结直肠NET的治疗算法。在日本结直肠癌学会下属机构中对大肠NET(结直肠和阑尾NET)进行了回顾性研究,并使用WHO 2010标准对2001年至2011年的760例神经内分泌肿瘤进行了重新评估,以阐明大肠NET的临床病理特征。接下来,分析与淋巴结转移的临床病理关系,以预测局部切除的直肠NET中的淋巴结转移情况。原发部位在718/760例(94.5%)为直肠,30/760例(3.9%)为结肠,12/760例(1.6%)为阑尾。患者以男性为主(61.6%),平均年龄58.7岁。65.4%的病例肿瘤大小<10mm。NET G1、G2、G3和混合性腺神经内分泌癌(MANEC)的比例分别为88.4%、6.3%、3.9%和1.3%。在760例肿瘤中,468例为局部切除,292例为行淋巴结清扫的手术切除。直肠NET中NET G1的比例较高,结肠和阑尾NET更常见的是G3和MANEC。在292例行手术切除的病例中,233例位于直肠的NET G1和G2用于预测淋巴结转移。淋巴管和血管侵犯是淋巴结转移的独立预测因素。NET G2病例的淋巴结转移比NET G1病例更频繁,但这不是淋巴结转移的独立预测因素。在98例手术切除的肿瘤大小<10mm的病例中,发现9例有淋巴结转移(9.2%)。所有病例均为NET G1,9例中的8例淋巴管侵犯或血管侵犯呈阳性。使用WHO分类,我们发现大肠NET显示出与肿瘤部位相关的多种组织学和临床病理特征。即使在小于10mm的病变中,直肠NET的淋巴结转移风险也得到了证实。对于小病变,需要对血管侵犯进行一致评估以估计淋巴结转移情况。

相似文献

1
Neuroendocrine Tumors of the Large Intestine: Clinicopathological Features and Predictive Factors of Lymph Node Metastasis.大肠神经内分泌肿瘤:临床病理特征及淋巴结转移的预测因素
Front Oncol. 2016 Jul 18;6:173. doi: 10.3389/fonc.2016.00173. eCollection 2016.
2
[Clinicopathologic characteristics and prognosis of rectal neuroendocrine neoplasms].直肠神经内分泌肿瘤的临床病理特征及预后
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Sep 25;20(9):1015-1019.
3
Grade G2 Rectal Neuroendocrine Tumor Is Much More Invasive Compared With G1 Tumor.G2级直肠神经内分泌肿瘤比G1级肿瘤更具侵袭性。
Front Oncol. 2021 Mar 11;11:646536. doi: 10.3389/fonc.2021.646536. eCollection 2021.
4
A nationwide, multi-institutional collaborative retrospective study of colorectal neuroendocrine tumors in Japan.日本一项关于结直肠神经内分泌肿瘤的全国性、多机构合作回顾性研究。
Ann Gastroenterol Surg. 2020 Nov 17;5(2):215-220. doi: 10.1002/ags3.12403. eCollection 2021 Mar.
5
[A Small Rectal Neuroendocrine Tumor of Less Than 5mm with Lymph Node Metastasis].[一例直径小于5mm且伴有淋巴结转移的直肠神经内分泌肿瘤]
Gan To Kagaku Ryoho. 2018 Dec;45(13):1985-1987.
6
Rectal neuroendocrine tumor with extracapsular lymph node metastasis: a case report.直肠神经内分泌肿瘤伴淋巴结外膜转移:病例报告。
Clin J Gastroenterol. 2021 Oct;14(5):1426-1430. doi: 10.1007/s12328-021-01447-x. Epub 2021 May 24.
7
[Clinicopathological classification and prognostic factors of gastrointestinal neuroendocrine neoplasms: an analysis of 119 cases].[胃肠神经内分泌肿瘤的临床病理分类及预后因素:119例分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Sep 25;20(9):997-1001.
8
Retrospective analysis of the clinicopathological characteristics of gastrointestinal neuroendocrine neoplasms.胃肠道神经内分泌肿瘤临床病理特征的回顾性分析
Exp Ther Med. 2015 Sep;10(3):1084-1088. doi: 10.3892/etm.2015.2634. Epub 2015 Jul 13.
9
A metastatic G2 neuroendocrine tumor smaller than 5 mm: A case report.一例直径小于5毫米的转移性G2神经内分泌肿瘤:病例报告。
Int J Surg Case Rep. 2022 May;94:107037. doi: 10.1016/j.ijscr.2022.107037. Epub 2022 Apr 5.
10
Single-incision laparoscopic ileocecal resection in a 10-year-old child with appendiceal neuroendocrine tumor.单切口腹腔镜回盲部切除术治疗 10 岁阑尾神经内分泌肿瘤患儿
World J Surg Oncol. 2019 Nov 26;17(1):197. doi: 10.1186/s12957-019-1745-y.

引用本文的文献

1
Epidemiological, Clinical and Biological Hemogram Features in a Cohort of Neuroendocrine Tumor Patients.一组神经内分泌肿瘤患者的流行病学、临床和生物学血常规特征
Curr Health Sci J. 2024 Apr-Jun;50(2):256-266. doi: 10.12865/CHSJ.50.02.11. Epub 2024 Jun 30.
2
Molecular Classification of Gastrointestinal and Pancreatic Neuroendocrine Neoplasms: Are We Ready for That?胃肠道和胰腺神经内分泌肿瘤的分子分类:我们为此做好准备了吗?
Endocr Pathol. 2024 Jun;35(2):91-106. doi: 10.1007/s12022-024-09807-2. Epub 2024 Mar 12.
3
Risk of metastasis and survival in patients undergoing different treatment strategies with T1 colonic neuroendocrine tumors.接受不同治疗策略的T1期结肠神经内分泌肿瘤患者的转移风险和生存率
J Endocrinol Invest. 2024 Mar;47(3):671-681. doi: 10.1007/s40618-023-02185-2. Epub 2023 Aug 31.
4
Preoperative prediction of lymphovascular invasion of colorectal cancer by radiomics based on 18F-FDG PET-CT and clinical factors.基于18F-FDG PET-CT和临床因素的结直肠癌淋巴管侵犯的放射组学术前预测
Front Radiol. 2023 Aug 8;3:1212382. doi: 10.3389/fradi.2023.1212382. eCollection 2023.
5
Immunoreactivity of HOXB13 in Neuroendocrine Neoplasms Is a Sensitive and Specific Marker of Rectal Well-Differentiated Neuroendocrine Tumors.HOXB13 在神经内分泌肿瘤中的免疫反应性是直肠高分化神经内分泌肿瘤的一个敏感且特异的标志物。
Endocr Pathol. 2023 Sep;34(3):333-341. doi: 10.1007/s12022-023-09779-9. Epub 2023 Aug 8.
6
Tumor grade 2 as the independent predictor for lymph node metastasis in 10-20 mm sized rectal neuroendocrine tumor.肿瘤2级是10 - 20毫米大小直肠神经内分泌肿瘤淋巴结转移的独立预测因素。
Korean J Clin Oncol. 2021 Jun;17(1):37-43. doi: 10.14216/kjco.21006. Epub 2021 Jun 30.
7
Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors.胃胰神经内分泌肿瘤(≤20mm)的淋巴结转移模式与最佳手术策略。
Front Endocrinol (Lausanne). 2022 Jul 21;13:871830. doi: 10.3389/fendo.2022.871830. eCollection 2022.
8
A metastatic G2 neuroendocrine tumor smaller than 5 mm: A case report.一例直径小于5毫米的转移性G2神经内分泌肿瘤:病例报告。
Int J Surg Case Rep. 2022 May;94:107037. doi: 10.1016/j.ijscr.2022.107037. Epub 2022 Apr 5.
9
Rectal neuroendocrine neoplasms: what the radiologists should know.直肠神经内分泌肿瘤:放射科医生应该知道的。
Abdom Radiol (NY). 2022 Dec;47(12):4016-4031. doi: 10.1007/s00261-022-03474-9. Epub 2022 Mar 14.
10
Mixed neuroendocrine-non-neuroendocrine neoplasms of the right colon: a case report.右半结肠混合性神经内分泌-非神经内分泌肿瘤:1 例报告。
Pan Afr Med J. 2021 Dec 21;40:243. doi: 10.11604/pamj.2021.40.243.30627. eCollection 2021.

本文引用的文献

1
Current status of the histopathological assessment, diagnosis, and reporting of colorectal neuroendocrine tumors: A Web survey from the Japanese Society for Cancer of Colon and Rectum.结直肠神经内分泌肿瘤的组织病理学评估、诊断及报告的现状:来自日本结直肠癌学会的网络调查
Pathol Int. 2016 Feb;66(2):94-101. doi: 10.1111/pin.12388.
2
ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms.《神经内分泌肿瘤学会(ENETS)结直肠神经内分泌肿瘤共识指南更新》
Neuroendocrinology. 2016;103(2):139-43. doi: 10.1159/000443166. Epub 2016 Jan 5.
3
Short- and long-term outcomes of endoscopic resection of rectal neuroendocrine tumours: analyses according to the WHO 2010 classification.直肠神经内分泌肿瘤内镜切除的短期和长期结果:根据世界卫生组织2010年分类进行的分析
Scand J Gastroenterol. 2016;51(4):448-55. doi: 10.3109/00365521.2015.1107752. Epub 2015 Nov 5.
4
Blood and lymphatic vessel invasion in pT1 colorectal cancer: an international concordance study.pT1期结直肠癌的血管及淋巴管侵犯:一项国际一致性研究
J Clin Pathol. 2015 Aug;68(8):628-32. doi: 10.1136/jclinpath-2014-202805. Epub 2015 Apr 30.
5
Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification.胰腺神经内分泌肿瘤:一项采用ENETS TNM分类和免疫组化标志物进行风险分层的单中心回顾性分析。
BMC Surg. 2015 Apr 25;15:49. doi: 10.1186/s12893-015-0033-1.
6
Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.单中心三级医疗机构中胃肠胰神经内分泌肿瘤原发肿瘤切除术后的生存预后因素:胃肠部位与胰腺部位的比较
Eur J Surg Oncol. 2015 Jun;41(6):751-7. doi: 10.1016/j.ejso.2015.02.011. Epub 2015 Apr 3.
7
A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study.基于黏膜下浸润深度和出芽/萌芽情况的三级分类系统可改善T1期结直肠癌的治疗策略:一项回顾性多中心研究
Mod Pathol. 2015 Jun;28(6):872-9. doi: 10.1038/modpathol.2015.36. Epub 2015 Feb 27.
8
Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.世界卫生组织2000/2004年与世界卫生组织2010年胃肠道和胰腺神经内分泌肿瘤分类的比较。
Ann Diagn Pathol. 2015 Apr;19(2):81-7. doi: 10.1016/j.anndiagpath.2015.01.001. Epub 2015 Jan 9.
9
Evaluation of the World Health Organization 2010 grading system in surgical outcome and prognosis of pancreatic neuroendocrine tumors.评价世界卫生组织 2010 年分级系统在胰腺神经内分泌肿瘤手术结果和预后中的应用。
Pancreas. 2014 Oct;43(7):1003-8. doi: 10.1097/MPA.0000000000000153.
10
Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors.病理分级和肿瘤大小与十二指肠神经内分泌肿瘤患者的无复发生存率相关。
J Gastrointest Surg. 2014 Mar;18(3):457-62; discussion 462-3. doi: 10.1007/s11605-014-2456-x. Epub 2014 Jan 22.